Tonsillar pseudotumor: Complications of chronically-administered temozolomide

Journal of Neuro-Oncology

Volumn 100, Issue 3, 2010, Pages 475-479

  Grisdale, Kathleen ^a   Ritterhouse, Melesa ^a   Hunter, Kathy ^a   Williams, Michelle D ^a   Groves, Morris D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cytomegalovirus; Epstein Barr Virus; Glioblastoma multiforme; Herpes Simplex Virus; Temozolomide

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN SURGERY; CANCER ADJUVANT THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOMEGALOVIRUS; DECREASED APPETITE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; GLIOBLASTOMA; HEMOGLOBIN BLOOD LEVEL; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LONG TERM EXPOSURE; LYMPHOCYTOPENIA; MULTIPLE CYCLE TREATMENT; ODYNOPHAGIA; PNEUMOCYSTIS PNEUMONIA; PSEUDOTUMOR; SIDE EFFECT; TONSIL DISEASE; TONSIL PSEUDOTUMOR; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MIDDLE AGED; PALATINE TONSIL;

EID: 78449295433     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0207-8     Document Type: Article

References (13)

1. R Stupp WP Mason, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 996 1:CAS:528: DC%2BD2MXit1Wksbk%3D 10.1056/NEJMoa043330 15758009
2. Pollack A (2009) Considering longer chemotherapy. The New York Times, New York
3. R Stupp ME Hegi, et al. 2009 Effects of radiotherapy with concomitant with adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 5 459 466 1:CAS:528:DC%2BD1MXlsVKhs74%3D 10.1016/S1470-2045(09)70025-7 19269895
4. JR Perry P Rizek, et al. 2008 Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach Cancer 113 8 2152 2157 1:CAS:528:DC%2BD1cXht12lu77J 10.1002/cncr.23813 18756530
5. WK Yung MD Prados, et al. 1999 Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group J Clin Oncol 17 9 2762 2771 1:CAS:528:DyaK1MXmtlWru7s%3D 10561351
6. MM Mrugala SK Johnston, et al. 2008 Cytopenias in patients with newly diagnosed high-grade gliomas receiving radiation and temozolomide-who is at risk? Neuro Oncol 10 6 1120 (abstract P156)
7. DE Gerber SA Grossman, et al. 2007 The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas Neuro Oncol 9 1 47 52 1:CAS:528:DC%2BD2sXht1Ojs7g%3D 10.1215/15228517-2006-024 17108062
8. YB Su S Sohn, et al. 2004 Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications J Clin Oncol 22 4 610 616 1:CAS:528:DC%2BD2cXpsVajs7s%3D 10.1200/JCO.2004.07.060 14726505
9. G Georgescu IM Isola, et al. 2008 Disseminated salmonellosis in a patient treated with temozolomide J Infect 57 5 414 415 10.1016/j.jinf.2008.06.021 18715650
10. P Hau D Koch, et al. 2007 Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma Neurology 68 9 688 690 1:CAS:528:DC%2BD2sXhvFWrs7c%3D 10.1212/01.wnl.0000255937.27012.ee 17325277
11. E Binello IM Germano 2009 Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology? J Neurooncol 94 1 145 148 1:CAS:528:DC%2BD1MXotFWhs7c%3D 10.1007/s11060-009-9806-7 19199004
12. M Tamm 1999 The lung in the immunocomprised patients. Infectious complications part 2 Respiration 66 3 199 207 1:STN:280:DyaK1M3psVygug%3D%3D 10.1159/000029377 10364733
13. R Snoeck 2000 Antiviral therapy of herpes simplex Int J Antimicrob Agents 16 2 157 159 1:CAS:528:DC%2BD3cXotFKgs7g%3D 10.1016/S0924-8579(00)00233-8 11053800